Mantis Therapeutics Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Mantis Therapeutics General Information
Description
Developer of transformational therapies designed to treat multiple types of cancer. The company offers bacteria-based targeted immunotherapy that elicits long-lived immunity and inhibits tumor progression, enabling healthcare professionals to improve treatment outcomes and reduce the risk of recurrence.
Contact Information
Website
www.mantispharma.comCorporate Office
- BioPartner 3 Building
- Bio Science Park, Galileiweg 8
- 2333 BD Leiden
- Netherlands
Corporate Office
- BioPartner 3 Building
- Bio Science Park, Galileiweg 8
- 2333 BD Leiden
- Netherlands
Mantis Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 30-Jun-2026 | Completed | Out of Business | |||
| 3. Accelerator/Incubator | 01-Jun-2021 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2016 | Completed | Startup | |||
| 1. Spin-Off | 01-Jan-2016 | Completed | Startup |
Mantis Therapeutics FAQs
-
When was Mantis Therapeutics founded?
Mantis Therapeutics was founded in 2016.
-
Where is Mantis Therapeutics headquartered?
Mantis Therapeutics is headquartered in Leiden, Netherlands.
-
What industry is Mantis Therapeutics in?
Mantis Therapeutics’s primary industry is Drug Discovery.
-
Is Mantis Therapeutics a private or public company?
Mantis Therapeutics is a Private company.
-
What is Mantis Therapeutics’s current revenue?
The current revenue for Mantis Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process